Proteinuria
≈ 5 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Proteinuria is the presence of excess proteins in the urine. In healthy persons, urine contains very little protein, less than 150 mg/day; an excess is suggestive of illness. Excess protein in the urine often causes the urine to become foamy (although this symptom may also be caused by other conditions). Severe proteinuria can cause nephrotic syndrome in which there is worsening swelling of the body.
Proteinuria is the presence of excess proteins in the urine. In healthy persons, urine contains very little protein, less than 150 mg/day; an excess is suggestive of illness. Excess protein in the urine often causes the urine to become foamy (although this symptom may also be caused by other conditions). Severe proteinuria can cause nephrotic syndrome in which there is worsening swelling of the body.
Signs and symptoms
Proteinuria often causes no symptoms and it may only be discovered incidentally. Foamy urine is considered a cardinal sign of proteinuria, but only a third of people with foamy urine have proteinuria as the underlying cause. It may also be caused by bilirubin in the urine (bilirubinuria), retrograde ejaculation, glycosuria, dehydration, a fast urine stream, pneumaturia (air bubbles in the urine) due to a fistula, or drugs such as phenazopyridine (trademarked as 'Pyridium').
Conditions with proteinuria
Proteinuria may be a feature of the following conditions: Nephrotic syndromes (i.e. intrinsic kidney failure) Pre-eclampsia Eclampsia Toxic lesions of kidneys Amyloidosis Collagen vascular diseases (e.g. systemic lupus erythematosus) Dehydration Glomerular diseases, such as membranous glomerulonephritis, focal segmental glomerulonephritis, minimal change disease (lipoid nephrosis) Strenuous exercise Stress Benign orthostatic (postural) proteinuria Focal segmental glomerulosclerosis (FSGS) IgA nephropathy (i.e. Berger's disease) IgM nephropathy Membranoproliferative glomerulonephritis Membranous nephropathy Minimal change disease Sarcoidosis Alport syndrome Diabetes mellitus (diabetic nephropathy) Drugs (e.g. NSAIDs, nicotine, penicillamine, lithium carbonate, gold and other heavy metals, ACE inhibitors, antibiotics, or opiates (especially heroin) Fabry disease Infections (e.g. HIV, syphilis, hepatitis, poststreptococcal infection, urinary schistosomiasis) Aminoaciduria Fanconi syndrome in association with Wilson disease Hypertensive nephrosclerosis Interstitial nephritis Sickle cell disease Hemoglobinuria Multiple myeloma Myoglobinuria Organ rejection: Ebola virus disease Nail–patella syndrome Familial Mediterranean fever HELLP syndrome Systemic lupus erythematosus Granulomatosis with polyangiitis Rheumatoid arthritis Glycogen storage disease type 1 Goodpasture syndrome Henoch–Schönlein purpura A urinary tract infection which has spread to the kidney(s) Sjögren syndrome Post-infectious glomerulonephritis Living kidney donor Polycystic kidney disease
Bence–Jones proteinuria
Amyloidosis Pre-malignant plasma cell dyscrasias: Monoclonal gammopathy of undetermined significance Smoldering multiple myeloma Malignant plasma cell dyscrasias Multiple myeloma Waldenström's macroglobulinemia Other malignancies Chronic lymphocytic leukemia Rare cases of other Lymphoid leukemias Rare cases of Lymphomas
Pathophysiology
Protein is the building block of all living organisms. When kidneys are functioning properly by filtering the blood, they distinguish the proteins from the wastes which were previously present together in the blood. Thereafter, kidneys retain or reabsorb the filtered proteins and return them to the circulating blood while removing wastes by excreting them in the urine. Whenever the kidney is compromised, their ability to filter the blood by differentiating protein from the waste, or retaining the filtered protein then returning which back to the body, is damaged. As a result, there is a significant amount of protein is discharged along with waste in the urine, which makes the concentration of proteins in urine high enough to be detected by well-known chemical tests. Elevated concentration of proteins in urine is not always caused by a kidney disease. Consumption of high amounts of protein with food can also result in such symptom.
Albumin and immunoglobins
Albumin is a protein produced by the liver which makes up roughly 50%-60% of the total proteins in the blood while the other 40%-50% are proteins other than albumin, such as immunoglobins. This is why the concentration of albumin in the urine is one of the single sensitive indicators of kidney disease, particularly for those with diabetes or hypertension, compared to routine proteinuria examination. As the loss of proteins from the body progresses, the illness becomes symptomatic. The exception applies to the scenario when there's an overproduction of proteins in the body, in which the kidney is not to blame.
Classification
Proteinuria may be classified as selective or non-selective. In selective proteinuria, the level of high molecular proteins such as immunoglobulin G in the excreted urine is low, whereas in non-selective proteinuria, it is high. Selective proteinuria, where proteins of smaller molecular weight pass through the filtration membrane whereas the content of large molecule proteins is low, suggests mild glomerular damage. The proteinuria selectivity index (PSI) may be calculated according to the formula: urine IgG/serum IgG and serum albumin/urine albumin. A PSI 30 mg/day correspond to a detection level within the "trace" to "1+" range of a urine dipstick protein assay. Therefore, positive indication of any protein detected on a urine dipstick assay obviates any need to perform a urine microalbumin test as the upper limit for microalbuminuria has already been exceeded.
Analysis
It is possible to analyze urine samples in determining albumin, hemoglobin and myoglobin with an optimized MEKC method.
Treatment
The most common cause is diabetic nephropathy; in this case, proper glycemic control may slow the progression. Medical management consists of angiotensin converting enzyme (ACE) inhibitors, which are typically first-line therapy for proteinuria. In patients whose proteinuria is not controlled with ACE inhibitors, the addition of an aldosterone antagonist (i.e., spironolactone) or angiotensin receptor blocker (ARB) may further reduce protein loss. Atrasentan (Vanrafia) was approved for medical use in the United States in April 2025.
See also
List of terms associated with diabetes Edmund Randerath
References
External links
Text derived from https://en.wikipedia.org/w/index.php?oldid=1355856772 under CC BY-SA 4.0; modifications have been made.